These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37779396)

  • 1. Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency.
    Gozzetti A; Bacchiarri F; Raspadori D; Sicuranza A; Sammartano V; Bocchia M
    Rev Recent Clin Trials; 2023; 18(4):300-303. PubMed ID: 37779396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases.
    Hoffman MA
    Med Oncol; 2011 Dec; 28(4):1537-41. PubMed ID: 20509009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
    Saven A; Burian C; Koziol JA; Piro LD
    Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56-Positive Acute Myeloid Leukemia Following Treatment of Hairy Cell Leukemia with Cladribine - Report of 2 Cases and Review of the Literature.
    Colovic N; Marisavljevic D; Kraguljac-Kurtovic N; Bogdanovic A; Gotic M
    Arch Iran Med; 2019 May; 22(5):269-271. PubMed ID: 31256601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report.
    Ecsiova D; Kamaradova K; Nova M; Hoffmann P; Rozsivalova P; Simkovic M; Zak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Dec; 167(4):385-389. PubMed ID: 35713332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful surgical resection of rectal cancer in a patient with relapsed hairy cell leukemia under interferon-α treatment].
    Oka T; Hirata H; Kitagawa T; Io K; Nagai K
    Rinsho Ketsueki; 2021; 62(12):1672-1677. PubMed ID: 35022335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine.
    Tombak A; Aygün S; Serinsöz E; Tiftik EN
    Korean J Intern Med; 2015 Sep; 30(5):739-41. PubMed ID: 26354071
    [No Abstract]   [Full Text] [Related]  

  • 15. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.
    Nieva J; Bethel K; Saven A
    Blood; 2003 Aug; 102(3):810-3. PubMed ID: 12663446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.
    Hilbe W; Berger T; Konwalinka G; Thaler J
    Acta Haematol; 1999; 102(2):99-100. PubMed ID: 10529514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hairy cell leukemia: therapeutic approaches].
    Paitel JF; Guerci A; Lederlin P
    Rev Med Interne; 1996; 17(5):399-406. PubMed ID: 8763100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
    Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.